Australia Stock Exchange release from NOVA EYE MED : Reducing Progression Rate Age-Related Macular Degeneration
19/12/2021 22:45
Australia Stock Exchange release from NOVA EYE MED EYE.AX : Reducing Progression Rate Age-Related Macular Degeneration
Recent news on Nova Eye Medical
See all newsAustralia's Nova Eye Medical jumps on upbeat FY27 earnings guidance
Brief: Nova Eye Medical Reports FY26 Sales Of $23.7 Million
Australia's Nova Eye Medical soars on FY26 sales forecast upgrade
Brief: Nova Eye Medical Upgrades Fy26 Sales Guidance (Ex-China) To $22–23 Million
Australia's Nova Eye Medical rises on EU approval for glaucoma treatment